IL125797A0 - Parapoxviruses which contain foreign dna their preparation and their use in vaccines - Google Patents

Parapoxviruses which contain foreign dna their preparation and their use in vaccines

Info

Publication number
IL125797A0
IL125797A0 IL12579797A IL12579797A IL125797A0 IL 125797 A0 IL125797 A0 IL 125797A0 IL 12579797 A IL12579797 A IL 12579797A IL 12579797 A IL12579797 A IL 12579797A IL 125797 A0 IL125797 A0 IL 125797A0
Authority
IL
Israel
Prior art keywords
parapoxviruses
vaccines
preparation
foreign dna
contain foreign
Prior art date
Application number
IL12579797A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19639601A external-priority patent/DE19639601A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL125797A0 publication Critical patent/IL125797A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24211Parapoxvirus, e.g. Orf virus
    • C12N2710/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24211Parapoxvirus, e.g. Orf virus
    • C12N2710/24241Use of virus, viral particle or viral elements as a vector
    • C12N2710/24243Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12579797A 1996-02-28 1997-02-17 Parapoxviruses which contain foreign dna their preparation and their use in vaccines IL125797A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19607458 1996-02-28
DE19639601A DE19639601A1 (de) 1996-02-28 1996-09-26 Parapockenviren, die Fremd-DNA enthalten, ihre Herstellung und ihre Verwendung in Impfstoffen
PCT/EP1997/000729 WO1997032029A1 (de) 1996-02-28 1997-02-17 Parapockenviren, die fremd-dna enthalten, ihre herstellung und ihre verwendung in impfstoffen

Publications (1)

Publication Number Publication Date
IL125797A0 true IL125797A0 (en) 1999-04-11

Family

ID=26023280

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12579797A IL125797A0 (en) 1996-02-28 1997-02-17 Parapoxviruses which contain foreign dna their preparation and their use in vaccines

Country Status (19)

Country Link
US (1) US6365393B1 (sk)
EP (1) EP0886679B1 (sk)
JP (1) JP2000507092A (sk)
CN (1) CN1217027A (sk)
AT (1) ATE364090T1 (sk)
AU (1) AU718141B2 (sk)
BR (1) BR9707785A (sk)
CA (1) CA2247336C (sk)
DE (1) DE59712852D1 (sk)
DK (1) DK0886679T3 (sk)
ES (1) ES2287949T3 (sk)
HU (1) HUP9901035A3 (sk)
IL (1) IL125797A0 (sk)
NO (1) NO983946L (sk)
NZ (1) NZ331556A (sk)
PL (1) PL190401B1 (sk)
SK (1) SK120098A3 (sk)
TR (1) TR199801702T2 (sk)
WO (1) WO1997032029A1 (sk)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126349A0 (en) * 1996-03-29 1999-05-09 Univ Otago Parapoxvirus vectors
AU758353B2 (en) * 1998-03-17 2003-03-20 Genentech Inc. Polypeptides homologous to VEGF and BMP1
JP2003517275A (ja) * 1998-11-02 2003-05-27 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ 哺乳動物vegfレセプター−2に結合し、これを活性化するオルフウイルスnz2由来の血管内皮細胞増殖因子様タンパク質
DE50109630D1 (de) * 2000-07-11 2006-06-01 Bayer Healthcare Ag Verwendung von stämmen des parapoxvirus ovis zur herstellung von antiviralen arzneimitteln und arzneimitteln gegen krebs
US6752995B2 (en) * 2002-04-15 2004-06-22 Board Of Regents, The University Of Texas System Nucleic acid and polypeptide sequences useful as adjuvants
EP1499355A4 (en) 2001-12-07 2005-10-05 Bayer Pharmaceuticals Corp USE OF PARAPOX B2L PROTEIN FOR THE TREATMENT OF CANCER AND THE MODIFICATION OF IMMUNE RESPONSES
EP1765370B1 (en) * 2004-07-13 2009-09-09 AiCuris GmbH & Co. KG Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids
KR20130058706A (ko) * 2010-04-29 2013-06-04 림사 아르쯔나이미텔 아게 토끼 출혈병 바이러스의 vp60 주요 캡시드 단백질을 발현하는 파라폭스바이러스
NZ603431A (en) * 2010-05-21 2014-06-27 Zoetis Llc Parapoxvirus vectors containing rabies virus antigen
JP2013537409A (ja) 2010-07-20 2013-10-03 ゾエティス・エルエルシー パラポックスウイルスベクター
MX2015000789A (es) 2012-07-19 2015-05-07 Zoetis Llc Composiciones de virus de la gripe bovina.
AU2013295770A1 (en) 2012-07-27 2015-01-29 Zoetis Services Llc Tick toxin compositions
DE102015111756A1 (de) * 2015-07-20 2017-01-26 Eberhard Karls Universität Tübingen Medizinische Fakultät Rekombinanter Orf-Virus-Vektor
CN108135989B (zh) 2015-08-14 2022-08-09 硕腾服务有限责任公司 牛支原体组合物
BR112018069371A2 (pt) 2016-03-21 2019-01-22 South Dakota Board Of Regents construção de ácido nucleico, vetor, vacina ou composição imunogênica, método de entrega de uma vacina, método de produção de uma construção de ácido nucleico e método para conferir imunidade contra um antígeno
MX2020009262A (es) 2018-03-07 2021-01-08 Transgene Vectores de parapoxvirus.
WO2024062098A1 (en) 2022-09-23 2024-03-28 Transgene Recombinant pseudocowpox virus encoding an interleukin-12

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CA2188447C (en) * 1994-04-29 2002-10-22 Falko-Gunter Falkner Recombinant poxviruses with foreign polynucleotides in essential regions

Also Published As

Publication number Publication date
NO983946L (no) 1998-10-22
CA2247336C (en) 2008-06-17
JP2000507092A (ja) 2000-06-13
HUP9901035A3 (en) 2001-01-29
AU1725797A (en) 1997-09-16
NO983946D0 (no) 1998-08-27
DE59712852D1 (de) 2007-07-19
ATE364090T1 (de) 2007-06-15
BR9707785A (pt) 1999-07-27
HUP9901035A2 (hu) 1999-07-28
PL328870A1 (en) 1999-03-01
DK0886679T3 (da) 2007-09-24
US6365393B1 (en) 2002-04-02
WO1997032029A1 (de) 1997-09-04
ES2287949T3 (es) 2007-12-16
PL190401B1 (pl) 2005-12-30
TR199801702T2 (xx) 1998-12-21
SK120098A3 (en) 1999-03-12
NZ331556A (en) 2000-05-26
CN1217027A (zh) 1999-05-19
EP0886679B1 (de) 2007-06-06
CA2247336A1 (en) 1997-09-04
AU718141B2 (en) 2000-04-06
EP0886679A1 (de) 1998-12-30

Similar Documents

Publication Publication Date Title
IL125797A0 (en) Parapoxviruses which contain foreign dna their preparation and their use in vaccines
EP0835133A4 (en) RECOMBINANT COMPOSITIONS AND COMBINED COMPOSITIONS OF RABIES AND SMALLPOX VIRUSES, AND USES THEREOF
WO2001034801A3 (en) Recombinant gelatin in vaccines
DE69529219D1 (en) Helicobacter proteine und impstoffe
EP0757717A4 (en) PAPILLOMAVIRUS VACCINES
WO1998016646A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO1998053075A3 (en) Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
MX9708426A (es) Polipeptido hk2 de variante estable.
ZA985393B (en) Clostridium perfringens vaccine
AU1815899A (en) Method and composition to enhance the efficacy of a vaccine using chemokines
AU6028898A (en) Methods for cultivating cells and propagating viruses
YU36698A (sh) Parapoks-virusi koji sadrže stranu dnk, njihovo dobijanje i njihova primena u vakcinama
AU3711597A (en) A novel galanin receptor
AU8467201A (en) Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
AU3058300A (en) Novel cationic couplers and their use for oxidation dyeing
NZ330913A (en) Antigens for preventing and reducing parasite infection and disease
NZ277605A (en) Human stanniocalcin-alpha polypeptide and dna (rna) encoding polypeptide; polypeptide may be derived from atcc 75861
CA2182315A1 (en) Expression of heterologous proteins in attenuated bacteria using the htra-promoters
AU3930895A (en) Viral preparations, immunogens, and vaccines
CA2475337A1 (en) Methods for cultivating cells and propagating viruses
EP0787136A4 (en) NEW PROTEINS RELATED TO OPACITY, DNA WHICH CODES THEM AND METHODS FOR THEIR USE
GB9603322D0 (en) Viral preparations,immunogens and vaccines
NZ507993A (en) Human deadenylating nuclease, its preparation and use